U.S. Newswire - African Americans Should Not Stop Taking Vytorin or Zetia Without Consulting Their Healthcare Providers
To: MEDICAL EDITORS
Contact: Keith Ferdinand, MD, 1-404-201-6632
ATLANTA, Jan. 24 /PRNewswire/ — The recent release of the
ENHANCE study of Vytorin and Zetia has drawn considerable media
attention, but stopping cholesterol medications based on this study
alone is not appropriate. The next step for any concerned patient
with high cholesterol is to talk with his/her healthcare provider
before making any changes in care, according to the Association of
Black Cardiologists, Inc.
Related Results
Merck and Schering-Plough's statin combo hits pharmacies
Vytorin study raises questions about Cholesterol’s Import
Drug trials under pressure
WALL STREET CHOICE: SCHERING-PLOUGH SHOWS PROMISE
Girard Gibbs LLP Investigates Possible Securities Laws Violations Concerning …
African Americans have the highest coronary heart disease (heart
attack) death rate in the United States and high …
Read the rest of this article with a Free Trial at HighBeam Research.
